Skadden is advising Otsuka, while Latham & Watkins is advising Jnana on the deal. Nutraceutical and pharmaceutical company Otsuka Holdings Co. Ltd., (Otsuka), announced the definitive...
Otsuka Pharmaceutical’s Acquisition of Jnana Therapeutics
Gilead’s $2 Billion Senior Unsecured Notes Offering
Davis Polk advised Gilead, and Latham & Watkins advised the underwriters. Gilead Sciences, Inc. (Nasdaq: GILD) announced the pricing of senior unsecured notes in an aggregate...
Cadence’s Acquisition of Rambus PHY IP Assets
Latham & Watkins advised Cadence, and Wilson Sonsini Goodrich & Rosati advised Rambus on the transaction. Cadence Design Systems, Inc. and Rambus Inc. announced that they have entered...
Aristocrat Leisure Limited’s $1.2 Billion Acquisition of NeoGames
Latham & Watkins and Herzog Fox acted as legal counsel to NeoGames. NeoGames S.A. (Nasdaq: NGMS) announced that it has entered into a definitive Business Combination Agreement...
CF Industries’ Acquisition of Waggaman Ammonia Production Facility from Incitec Pivot Limited
Skadden, Arps, Slate, Meagher & Flom represented CF Industries, and Latham & Watkins represented Incitec Pivot. CF Industries Holdings, Inc. (NYSE: CF), a leading global manufacturer...